# Primmune Therapeutics, Inc.

Canonical: https://abierto.us/vendors/primmune-therapeutics-inc-rce3kw671h83

- UEI: RCE3KW671H83
- CAGE: 8J8L4
- Location: Carlsbad, CA
- Awards in window: 1 (14 transactions), $11,211,689 obligated, January 30, 2024 to April 20, 2026

## Awarding agencies

- Defense Threat Reduction Agency: 1 awards, $11,211,689

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $11,211,689

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- HDTRA124C0014 (definitive contract): $11,211,689, Defense Threat Reduction Agency. Oral Broad Spectrum Antiviral TLR7 Agonist for Treatment of Lassa Fever. https://www.usaspending.gov/award/CONT_AWD_HDTRA124C0014_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/primmune-therapeutics-inc-rce3kw671h83.